Quick Answer
Akebia Therapeutics, Inc. reported Shares Outstanding of 265.42 million shares for fiscal year 2025.
Akebia Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 265.42M | +18.0% |
| 2024 | 224.85M | +15.6% |
| 2023 | 194.58M | +5.7% |
| 2022 | 184.14M | +4.0% |
| 2021 | 177.00M | +19.5% |
| 2020 | 148.07M | +21.7% |
| 2019 | 121.67M | +4.1% |
| 2018 | 116.89M | +145.5% |
| 2017 | 47.61M | +23.3% |
| 2016 | 38.62M | +25.9% |
| 2015 | 30.66M | +50.5% |
| 2014 | 20.37M | +1372.6% |
| 2013 | 1.38M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 265.23M | +25.4% | +0.8% |
| June 30, 2025 | 263.04M | +25.3% | +0.5% |
| March 31, 2025 | 261.64M | +24.9% | +16.4% |
| December 31, 2024 | 224.85M | +15.6% | +6.3% |
| September 30, 2024 | 211.54M | +12.3% | +0.8% |
| June 30, 2024 | 209.93M | +11.6% | +0.2% |
| March 31, 2024 | 209.45M | +12.7% | +7.6% |
| December 31, 2023 | 194.58M | +5.7% | +3.3% |
- Akebia Therapeutics, Inc. showed an increase of +18.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, Akebia Therapeutics, Inc.’s shares outstanding has grown by 19087.2% (from 1.38 million shares to 265.42 million shares).
- The most recent figure is from Akebia Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: